Navigation Links
Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
Date:12/1/2008

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- On Monday, December 1, 2008, at 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific, Cell Therapeutics, Inc.'s (CTI) (Nasdaq and MTA: CTIC) management team will host a conference call to discuss the agreement with Spectrum Pharmaceuticals of Irvine, California to jointly market and develop Zevalin(R). The call will be webcast with slides, and the slides are also available for review on CTI's website, http://www.celltherapeutics.com/investor_updates.

    Conference Call Numbers
    Monday, December 1
    8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time
    1-800-219-6110 (US Participants)
    1-303-262-2053 (International)

    Call-back numbers for post-listening available at 11:30 a.m. Eastern:
    1-800-405-2236 (US Participants)
    1-303-590-3000 (International)
    Passcode: 11123066#

Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.

    Slides for the webcast can be accessed at:
http://www.celltherapeutics.com/investor_updates

    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    F: 206.272.4434
    E: media@ctiseattle.com
    www.celltherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.272.4345
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434
    E: invest@ctiseattle.com
    www.celltherapeutics.com/investors

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013   Lexicon Pharmaceuticals, Inc. ... company focused on discovering breakthrough treatments for human ... has joined the company as its vice president ... brings extensive commercial experience to Lexicon, including both ... of therapeutic areas. Mr. Northcott has ...
(Date:6/18/2013)... Though health care jobs continued to be added ... Labor Statistics -- the increase was far below the calendar ... care jobs were added in home health care and outpatient ... jobs. Overall, the U.S. unemployment rate stayed flat at 7.6 ... that a total of just over 36,000 job cuts were ...
(Date:6/18/2013)... 18, 2013 PathoGenetix, Inc. ... for rapid bacterial strain typing, announced today that ... company as Vice President of Engineering. Dr. Luckey ... company’s RESOLUTION™ Microbial Genotyping System . The ... instrument, pathogen-specific assay kits, database and software, will ...
(Date:6/18/2013)... June 18, 2013 On June 11, ... released a final decision memorandum concluding that FDG ... subsequent management of anti-tumor strategy, and the agency ... National Oncological PET Registry (NOPR) was developed jointly by ... projects under the Coverage with Evidence Development (CED) program ...
Breaking Biology Technology:John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3
... IRVINE, Calif., Sept. 10 ISTA Pharmaceuticals, Inc. (Nasdaq: ... NewsMakers in the Biotech Industry Conference at 11:30 a.m. Eastern ... in New York, NY. , , ISTA,s ... Silvernail will provide an update on the Company,s commercial and ...
... Md., Sept. 10 Cylex, Inc., a venture-backed global ... in vitro diagnostic products intended to illuminate ... Brad L. Stewart, to chief executive officer and chairman ... in December 2007, Mr. Stewart has successfully led the ...
... , , , DALLAS, Sept. ... (OTC Bulletin Board: ACCP), provided an update today on the Company,s clinical development ... drug that has shown to be active in many ... team recently met with its partners Aosaikang Medicinal Group (ASK) ...
Cached Biology Technology:Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 2Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 3Cylex, Inc. Appoints Brad L. Stewart as Chief Executive Officer and Chairman of the Board 4Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 2Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 3Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan 4
(Date:6/17/2013)... CORVALLIS, Ore. Amphibian populations are declining worldwide and ... be spread by bullfrogs, but a two-year study shows ... suggestions that bullfrogs are a tolerant carrier host that ... frogs from eggs in controlled experimental conditions, they found ... dendrobatidis , also called Bd or a chytrid fungus, ...
(Date:6/17/2013)... in French . ... mice with Alzheimer,s disease can be reversed with treatment. The ... - The Neuro, at McGill University and at Universit de ... in the brain of mice with advanced Alzheimer,s disease (AD) ... Journal of Neuroinflammation in May, also suggest an ...
(Date:6/16/2013)... SAN FRANCISCO (June 16, 2013)Male mice who were fed ... to father offspring who also had higher levels of ... The effect was observed primarily in male offspring, despite ... at the annual meeting of The Endocrine Society in ... traits that may affect metabolism and behavior of offspring ...
Breaking Biology News(10 mins):Bullfrogs may help spread deadly amphibian fungus, but also die from it 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Obese male mice father offspring with higher levels of body fat 2
... is a universal phenomenon that occurs in biological ... to population dynamics across thousands of kilometers. ... Synthesis (NIMBioS) is now accepting applications for its ... to be held April 11-13, 2011, at NIMBioS ...
... published in the journal Archives of Toxicology , ... in part caused by poorly-bound iron which causes the ... components of living systems. , These toxins, called hydroxyl ... parts of the body. , In order to protect ...
... antibiotic is consumed, researchers have learned that up to ... This means the drugs can leave the body almost ... of agricultural areas, excreted antibiotics can then enter stream ... discharges from animal feeding operations, fish hatcheries, and nonpoint ...
Cached Biology News:See off Alzheimer's with the color purple 2Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution 2Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution 3
Screening assay to detect the Listeria monocytogenes in food samples by,DNA amplification and molecular hybridization on a microtiter plate....
... HistoMark Biotin Streptavidin-HRP Systems provide ... and intracellular antigens in frozen or ... These systems also facilitate double ... can be performed simultaneously with primary ...
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... three step procedure (PCR, Exonuclease III digestion ... one day. The typical cloning efficiency using ... Features and Benefits: , , Universal - ... expression vector , High Cloning Efficiency - ...
Biology Products: